SE0101771D0 - Novel compounds - Google Patents
Novel compoundsInfo
- Publication number
- SE0101771D0 SE0101771D0 SE0101771A SE0101771A SE0101771D0 SE 0101771 D0 SE0101771 D0 SE 0101771D0 SE 0101771 A SE0101771 A SE 0101771A SE 0101771 A SE0101771 A SE 0101771A SE 0101771 D0 SE0101771 D0 SE 0101771D0
- Authority
- SE
- Sweden
- Prior art keywords
- sub
- ring
- phenyl
- novel compounds
- compounds
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 3
- 125000001072 heteroaryl group Chemical group 0.000 abstract 2
- 208000019901 Anxiety disease Diseases 0.000 abstract 1
- 208000018522 Gastrointestinal disease Diseases 0.000 abstract 1
- 208000027520 Somatoform disease Diseases 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 230000036506 anxiety Effects 0.000 abstract 1
- 125000001246 bromo group Chemical group Br* 0.000 abstract 1
- 125000001309 chloro group Chemical group Cl* 0.000 abstract 1
- 125000004122 cyclic group Chemical group 0.000 abstract 1
- 125000001153 fluoro group Chemical group F* 0.000 abstract 1
- 125000002541 furyl group Chemical group 0.000 abstract 1
- 125000002883 imidazolyl group Chemical group 0.000 abstract 1
- 125000002346 iodo group Chemical group I* 0.000 abstract 1
- 208000027753 pain disease Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- ILVXOBCQQYKLDS-UHFFFAOYSA-N pyridine N-oxide Chemical compound [O-][N+]1=CC=CC=C1 ILVXOBCQQYKLDS-UHFFFAOYSA-N 0.000 abstract 1
- 125000004076 pyridyl group Chemical group 0.000 abstract 1
- 125000000168 pyrrolyl group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- 238000006467 substitution reaction Methods 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- 125000000335 thiazolyl group Chemical group 0.000 abstract 1
- 125000001544 thienyl group Chemical group 0.000 abstract 1
- 125000001425 triazolyl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Pyridine Compounds (AREA)
Priority Applications (23)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0101771A SE0101771D0 (sv) | 2001-05-18 | 2001-05-18 | Novel compounds |
| US10/477,633 US7186733B2 (en) | 2001-05-18 | 2002-05-16 | 4-(phenyl-(piperidin-4yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| BR0209675-7A BR0209675A (pt) | 2001-05-18 | 2002-05-16 | Composto, processo para preparar o mesmo, uso de um composto, composição farmacêutica, e, métodos para o tratamento da dor, de distúrbios gastrintestinais funcionais, e da ansiedade |
| CZ20033091A CZ20033091A3 (cs) | 2001-05-18 | 2002-05-16 | 4-[Fenyl (piperidin-4-yl)amino] benzamidové deriváty a jejich použití pro ošetřování bolesti, úzkosti nebo gastrointestinálních poruch |
| MXPA03010442A MXPA03010442A (es) | 2001-05-18 | 2002-05-16 | Derivados de 4-(fenil-(piperidin-4-il)-amino)-benzamida y sus usos para tratamiento de dolor, ansiedad o desordenes gastrointestinales. |
| CNA028141733A CN1541203A (zh) | 2001-05-18 | 2002-05-16 | 4-(苯基-(哌啶-4基)-氨基)-苯甲酰胺衍生物及其在治疗疼痛、焦虑症或胃肠病中的应用 |
| PL02366770A PL366770A1 (en) | 2001-05-18 | 2002-05-16 | 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| IL15863002A IL158630A0 (en) | 2001-05-18 | 2002-05-16 | 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| CA002446316A CA2446316A1 (en) | 2001-05-18 | 2002-05-16 | 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| ARP020101816A AR033760A1 (es) | 2001-05-18 | 2002-05-16 | Derivados de 4-(fenil-(piperidin-4-il)amino)benzamida |
| SK13972003A SK13972003A3 (en) | 2001-05-18 | 2002-05-16 | 4-(Phenyl(piperidin-4-yl) amino) benzamide derivatives and use thereof for the treatment of pain, anxiety or gastrointestinal disorders |
| JP2002591457A JP2005508290A (ja) | 2001-05-18 | 2002-05-16 | ４−（フェニル−（ピペリジン−４−イル）−アミノ）−ベンズアミド誘導体及び疼痛、不安症又は胃腸障害の治療のためのその使用 |
| PCT/SE2002/000955 WO2002094784A1 (en) | 2001-05-18 | 2002-05-16 | 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| RU2003131965/04A RU2003131965A (ru) | 2001-05-18 | 2002-05-16 | Производные 4-(фенил-(пиперидин-4-ил)-амино)-бензамида и их применение для лечения боли, тревоги или желудочно-кишечных расстройств |
| EP02733711A EP1395556A1 (en) | 2001-05-18 | 2002-05-16 | 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| HU0401324A HUP0401324A2 (hu) | 2001-05-18 | 2002-05-16 | 4-[Fenil-(piperidinil)-amino]-benzamid-származékok és alkalmazásuk fájdalom, szorongás vagy gasztrointesztinális zavarok kezelésére |
| KR10-2003-7014949A KR20040000470A (ko) | 2001-05-18 | 2002-05-16 | 4-(페닐-(피페리딘-4-일)-아미노)-벤즈아미드 유도체 및통증, 불안증 또는 위장관 장애의 치료를 위한 그의 용도 |
| EEP200300535A EE200300535A (et) | 2001-05-18 | 2002-05-16 | 4-(fenüül(piperidiin-4-üül)amino)bensamiidi derivaadid ja nende kasutamine valu, ärevuse või seedetrakti häirete raviks |
| ZA200308641A ZA200308641B (en) | 2001-05-18 | 2003-11-05 | 4-(Phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders. |
| BG108332A BG108332A (bg) | 2001-05-18 | 2003-11-07 | 4-(фенил-(пиперидин-4-ил)-амино)-бензамидни производни и тяхното използване за лечение на болка, потиснатост или стомашно-чревни разстройства |
| CO03100168A CO5540318A2 (es) | 2001-05-18 | 2003-11-12 | Derivados de 4-(fenil-(piperidin-4-il)-amino)-benzamida y sus usos para el tratamiento del dolor, la ansiedad o desordenes gastrointestinales |
| IS7029A IS7029A (is) | 2001-05-18 | 2003-11-12 | 4-(fenýl-(píperidín-4-ýl)-amínó)-bensamíðafleiðurog notkun þeirra til meðhöndlunar á sársauka, kvíða eða truflunum í maga og þörmum |
| NO20035114A NO20035114D0 (no) | 2001-05-18 | 2003-11-17 | 4-(fenyl-(piperidin-4-yl)-amino)-benzamidderivater og deres anvendelse vedbehandling av angst, smerte eller gastrointestinale forstyrrelser |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0101771A SE0101771D0 (sv) | 2001-05-18 | 2001-05-18 | Novel compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE0101771D0 true SE0101771D0 (sv) | 2001-05-18 |
Family
ID=20284174
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE0101771A SE0101771D0 (sv) | 2001-05-18 | 2001-05-18 | Novel compounds |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US7186733B2 (cs) |
| EP (1) | EP1395556A1 (cs) |
| JP (1) | JP2005508290A (cs) |
| KR (1) | KR20040000470A (cs) |
| CN (1) | CN1541203A (cs) |
| AR (1) | AR033760A1 (cs) |
| BG (1) | BG108332A (cs) |
| BR (1) | BR0209675A (cs) |
| CA (1) | CA2446316A1 (cs) |
| CO (1) | CO5540318A2 (cs) |
| CZ (1) | CZ20033091A3 (cs) |
| EE (1) | EE200300535A (cs) |
| HU (1) | HUP0401324A2 (cs) |
| IL (1) | IL158630A0 (cs) |
| IS (1) | IS7029A (cs) |
| MX (1) | MXPA03010442A (cs) |
| NO (1) | NO20035114D0 (cs) |
| PL (1) | PL366770A1 (cs) |
| RU (1) | RU2003131965A (cs) |
| SE (1) | SE0101771D0 (cs) |
| SK (1) | SK13972003A3 (cs) |
| WO (1) | WO2002094784A1 (cs) |
| ZA (1) | ZA200308641B (cs) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR0307624A (pt) * | 2002-03-13 | 2005-01-11 | Janssen Pharmaceutica Nv | Inibidores de histona desacetilase |
| SE0300987D0 (sv) * | 2003-04-03 | 2003-04-03 | Astrazeneca Ab | Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof |
| KR20140015122A (ko) | 2003-10-01 | 2014-02-06 | 아돌로 코포레이션 | 스피로시클릭 헤테로시클릭 유도체 및 이의 사용 방법 |
| US7598261B2 (en) | 2005-03-31 | 2009-10-06 | Adolor Corporation | Spirocyclic heterocyclic derivatives and methods of their use |
| US7576207B2 (en) | 2006-04-06 | 2009-08-18 | Adolor Corporation | Spirocyclic heterocyclic derivatives and methods of their use |
| CN103724366B (zh) * | 2014-01-21 | 2016-04-27 | 贵州威顿晶磷电子材料股份有限公司 | 一种对羧基苯硼酸的制备方法 |
| RS60744B1 (sr) * | 2014-12-19 | 2020-10-30 | Pharmnovo Ab | Derivati diarilmetilideni pipiredina i njihova upotreba kao agonista delta opioidnih receptora |
| US20250084091A1 (en) * | 2021-05-04 | 2025-03-13 | The Texas A&M University System | Inhibitors of sars-cov-2 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4091096A (en) * | 1976-03-19 | 1978-05-23 | Eli Lilly And Company | Dinitroanilines for the control of phytopathogens |
| EG12406A (en) * | 1976-08-12 | 1979-03-31 | Janssen Pharmaceutica Nv | Process for preparing of novel n-aryl-n-(1-l-4-piperidinyl)-arylacetamides |
| SE441448B (sv) | 1977-05-23 | 1985-10-07 | Pfizer | Sett att framstella hexahydro-gamma-karbolinforeningar |
| US4252812A (en) * | 1977-05-23 | 1981-02-24 | Pfizer Inc. | 2-Substituted-trans-5-aryl-2,3,4,4a,5,9b-hexahydro-1H-pyrido[4,3-b]indoles |
| DE3200304A1 (de) * | 1981-01-16 | 1982-08-26 | Sandoz-Patent-GmbH, 7850 Lörrach | 3-aminopropoxyaryl-derivate, ihre herstellung und sie enthaltende arzneimittel |
| DE3563964D1 (en) * | 1984-10-16 | 1988-09-01 | Synthelabo | Piperidine derivatives, their preparation and their therapeutical application |
| US5188693A (en) * | 1986-04-18 | 1993-02-23 | Aishin Kakou K.K. | Process for applying polyvinyl chloride sealing material having low thixotropic index |
| YU150489A (sh) * | 1989-08-10 | 1992-12-21 | W.L. Gore & Co. Gmbh. | Uređaj za ispitivanje odevnih predmeta na nepromočivost |
| KR940003491B1 (ko) | 1989-08-10 | 1994-04-23 | 리히터 게데온 베기에스제티 기아르 알.티 | 4,4-이중 치환된 피페리딘 유도체와 그 제조방법 및 상기 화합물을 함유하는 약제학적 조성물 |
| US5854245A (en) * | 1996-06-28 | 1998-12-29 | Merck & Co., Inc. | Fibrinogen receptor antagonists |
| TW548271B (en) * | 1996-12-20 | 2003-08-21 | Astra Pharma Inc | Novel piperidine derivatives having an exocyclic double bond with analgesic effects |
| SE9604786D0 (sv) * | 1996-12-20 | 1996-12-20 | Astra Pharma Inc | New compounds |
| DE69831876T2 (de) | 1997-12-24 | 2006-07-27 | Ortho-Mcneil Pharmaceutical, Inc. | (4)-[aryl(piperidin-4-yl) aminobenzamidderivate die an delta-opioid rezeptor binden |
| WO1999045925A1 (en) | 1998-03-10 | 1999-09-16 | Research Triangle Institute | Novel opiate compounds, methods of making and methods of use |
| SE9904675D0 (sv) | 1999-12-20 | 1999-12-20 | Astra Pharma Inc | Novel compounds |
| KR20030009376A (ko) * | 2000-03-03 | 2003-01-29 | 오르토-맥네일 파마슈티칼, 인코퍼레이티드 | 3-(디아릴메틸렌)-8-아자비사이클로[3.2.1]옥탄 유도체 |
| US6556387B1 (en) * | 2000-03-31 | 2003-04-29 | Seagate Technology Llc | Controlling mechanical response characteristics of a disc drive actuator by adjusting a fastener engaging the actuator shaft to vary axial force on the bearing assembly |
| SE0001207D0 (sv) * | 2000-04-04 | 2000-04-04 | Astrazeneca Canada Inc | Novel compounds |
-
2001
- 2001-05-18 SE SE0101771A patent/SE0101771D0/xx unknown
-
2002
- 2002-05-16 JP JP2002591457A patent/JP2005508290A/ja active Pending
- 2002-05-16 CN CNA028141733A patent/CN1541203A/zh active Pending
- 2002-05-16 EP EP02733711A patent/EP1395556A1/en not_active Withdrawn
- 2002-05-16 MX MXPA03010442A patent/MXPA03010442A/es unknown
- 2002-05-16 HU HU0401324A patent/HUP0401324A2/hu unknown
- 2002-05-16 SK SK13972003A patent/SK13972003A3/sk unknown
- 2002-05-16 CA CA002446316A patent/CA2446316A1/en not_active Abandoned
- 2002-05-16 BR BR0209675-7A patent/BR0209675A/pt not_active Application Discontinuation
- 2002-05-16 IL IL15863002A patent/IL158630A0/xx unknown
- 2002-05-16 CZ CZ20033091A patent/CZ20033091A3/cs unknown
- 2002-05-16 PL PL02366770A patent/PL366770A1/xx not_active Application Discontinuation
- 2002-05-16 KR KR10-2003-7014949A patent/KR20040000470A/ko not_active Withdrawn
- 2002-05-16 RU RU2003131965/04A patent/RU2003131965A/ru not_active Application Discontinuation
- 2002-05-16 WO PCT/SE2002/000955 patent/WO2002094784A1/en not_active Application Discontinuation
- 2002-05-16 US US10/477,633 patent/US7186733B2/en not_active Expired - Fee Related
- 2002-05-16 AR ARP020101816A patent/AR033760A1/es not_active Application Discontinuation
- 2002-05-16 EE EEP200300535A patent/EE200300535A/xx unknown
-
2003
- 2003-11-05 ZA ZA200308641A patent/ZA200308641B/en unknown
- 2003-11-07 BG BG108332A patent/BG108332A/bg unknown
- 2003-11-12 CO CO03100168A patent/CO5540318A2/es not_active Application Discontinuation
- 2003-11-12 IS IS7029A patent/IS7029A/is unknown
- 2003-11-17 NO NO20035114A patent/NO20035114D0/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| HUP0401324A2 (hu) | 2004-11-29 |
| WO2002094784A1 (en) | 2002-11-28 |
| IS7029A (is) | 2003-11-12 |
| IL158630A0 (en) | 2004-05-12 |
| PL366770A1 (en) | 2005-02-07 |
| US7186733B2 (en) | 2007-03-06 |
| CA2446316A1 (en) | 2002-11-28 |
| NO20035114D0 (no) | 2003-11-17 |
| AR033760A1 (es) | 2004-01-07 |
| MXPA03010442A (es) | 2004-03-09 |
| KR20040000470A (ko) | 2004-01-03 |
| CO5540318A2 (es) | 2005-07-29 |
| RU2003131965A (ru) | 2005-05-10 |
| CZ20033091A3 (cs) | 2004-07-14 |
| SK13972003A3 (en) | 2004-10-05 |
| JP2005508290A (ja) | 2005-03-31 |
| CN1541203A (zh) | 2004-10-27 |
| BG108332A (bg) | 2004-12-30 |
| US20040142965A1 (en) | 2004-07-22 |
| EE200300535A (et) | 2004-02-16 |
| ZA200308641B (en) | 2005-02-07 |
| BR0209675A (pt) | 2004-07-27 |
| EP1395556A1 (en) | 2004-03-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2002094794A8 (en) | 4 (phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain anxiety or gastrointestinal disorders | |
| SE0001207D0 (sv) | Novel compounds | |
| SE0101765D0 (sv) | Novel compounds | |
| SE0103313D0 (sv) | Novel compounds | |
| SE0101766D0 (sv) | Novel compounds | |
| SE0001208D0 (sv) | Novel compounds | |
| DK1242402T3 (da) | Nye forbindelser | |
| SE0001209D0 (sv) | Novel compounds | |
| SE0101771D0 (sv) | Novel compounds | |
| SE0101768D0 (sv) | Novel compounds | |
| BG106807A (en) | Novel compounds | |
| SE0101767D0 (sv) | Novel compounds | |
| SE0101770D0 (sv) | Novel compounds | |
| SE0101769D0 (sv) | Novel compounds | |
| SE0101773D0 (sv) | Novel compounds | |
| SE0101772D0 (sv) | Novel compounds |